Ajanta Pharma consolidated net profit declines 5.05% in the March 2022 quarter

10 May 2022 , 02:37 PM

Net profit of Ajanta Pharma declined 5.05% to Rs 151.21 crore in the quarter ended March 2022 as against Rs 159.26 crore during the previous quarter ended March 2021. Sales rose 14.99% to Rs 870.29 crore in the quarter ended March 2022 as against Rs 756.84 crore during the previous quarter ended March 2021. For the full year,net profit rose 8.99% to Rs 712.68 crore in the year ended March 2022 as against Rs 653.87 crore during the previous year ended March 2021. Sales rose 15.62% to Rs 3340.99 crore in the year ended March 2022 as against Rs 2889.69 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	870.29	756.84	15	3340.99	2889.69	16
OPM %	23.75	34.28	–	27.82	34.56	–
PBDT	228.83	259.38	-12	1034.78	1016.27	2
PBT	197.67	228.78	-14	909.48	900.18	1
NP	151.21	159.26	-5	712.68	653.87	9

Powered by Capital Market – Live News